ABMD
Abiomed Inc.
$381.02
Earnings Summary
Revenue | $265.92Mn |
Net Profits | $106.13Mn |
Net Profit Margins | 39.91% |
Highlights
Abiomed Inc.’s revenue jumped 7.16% since last year same period to $265.92Mn in the Q3 2022. On a quarterly growth basis, Abiomed Inc. has generated -4.05% fall in its revenue since last 3-months.
Abiomed Inc.’s net profit jumped 86.35% since last year same period to $106.13Mn in the Q3 2022. On a quarterly growth basis, Abiomed Inc. has generated 94.55% jump in its net profits since last 3-months.
Abiomed Inc.’s net profit margin jumped 73.89% since last year same period to 39.91% in the Q3 2022. On a quarterly growth basis, Abiomed Inc. has generated 102.76% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Abiomed Inc. post its latest quarter earnings
EPS Estimate Current Quarter | 1.09 |
EPS Estimate Current Year | 1.09 |
Highlights
Abiomed Inc.’s earning per share (EPS) estimates for the current quarter stand at 1.09 - a 4.81% jump from last quarter’s estimates.
Abiomed Inc.’s earning per share (EPS) estimates for the current year stand at 1.09.
Key Ratios
Key ratios of the Abiomed Inc. post its Q3 2022 earnings
Earning Per Share (EPS) | 1.3 |
Highlights
Abiomed Inc.’s earning per share (EPS) jumped 26.21% since last year same period to 1.3 in the Q3 2022. This indicates that the Abiomed Inc. has generated 26.21% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2022-11-03 | 1.04 | 1.3 | 25% |
2022-08-04 | 1.06 | 1.25 | 17.92% |
2022-05-20 | 1.09 | 1.16 | 6.42% |
₹0 US Stocks a/c Opening Fee